Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial. (nature.com)

Authors: Peng Z … Shen L Journal: Nature Medicine Published: 2026-06-01 DOI: https://doi.org/10.1038/s41591-026-04459-7